[F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma

[F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma

Therapy monitoring of glioma after stereotactic iodine-125 brachytherapy (SBT) remains challenging because posttherapeutic changes in magnetic resonance imaging can mimic tumor progression. We evaluated the prognostic value of serial [ 18 F]fluoroethyltyrosine (FET)-positron emission tomographic (PE...

Full description

Bibliographic Details
Main Authors: Nathalie L. Jansen, Bogdana Suchorska, Silke B. Schwarz, Sabina Eigenbrod, Juergen Lutz, Vera Graute, Peter Bartenstein, Claus Belka, Friedrich W. Kreth, Christian la Fougère
Format: Article
Language:English
Published: SAGE Publications 2013-05-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2012.00027

Internet

https://doi.org/10.2310/7290.2012.00027

Similar Items